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Background: Sheep scab is a highly contagious disease of sheep caused by the ectoparasitic mite Psoroptes ovis.
The disease is endemic in the UK and has significant economic impact through its effects on performance and
welfare. Diagnosis of sheep scab is achieved through observation of clinical signs e.g. itching, pruritis and wool loss
and ultimately through the detection of mites in skin scrapings. Early stages of infestation are often difficult to
diagnose and sub-clinical animals can be a major factor in disease spread. The development of a diagnostic assay
would enable farmers and veterinarians to detect disease at an early stage, reducing the risk of developing clinical
disease and limiting spread.
Methods: Serum samples were obtained from an outbreak of sheep scab within an experimental flock (n = 480 (3
samples each from 160 sheep)) allowing the assessment, by ELISA of sheep scab specific antibody prior to
infestation, mid-outbreak (combined with clinical assessment) and post-treatment.
Results: Analysis of pre-infestation samples demonstrated low levels of potential false positives (3.8%). Of the 27
animals with clinical or behavioural signs of disease 25 tested positive at the mid-outbreak sampling period,
however, the remaining 2 sheep tested positive at the subsequent sampling period. Clinical assessment revealed
the absence of clinical or behavioural signs of disease in 132 sheep, whilst analysis of mid-outbreak samples
showed that 105 of these clinically negative animals were serologically positive, representing potential sub-clinical
infestations.
Conclusions: This study demonstrates that this ELISA test can effectively diagnose sheep scab in a natural
outbreak of disease, and more importantly, highlights its ability to detect sub-clinically infested animals. This ELISA,
employing a single recombinant antigen, represents a major step forward in the diagnosis of sheep scab and may
prove to be critical in any future control program.
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Background
Sheep scab is caused by the mite Psoroptes ovis and is,
arguably, the most important ectoparasitic disease of
sheep in the UK. Recent data relating to the financial
impact of sheep scab suggest that the disease costs the
UK sheep industry in excess of £8 million per annum,
including costs associated with lost performance, pre-
ventative measures, and treatment of affected animals;
with the major costs relating to disease prevention [1].
S i n c ei t sd e r e g u l a t i o na san o t i f i a b l ed i s e a s ei n1 9 9 2 ,
sheep scab has become endemic throughout the UK [2].
T h ed i s e a s ei sh i g h l yc o n t a g i ous, causing considerable
pruritis and irritation and is a major welfare concern
[3]. Current disease control strategies are reliant upon
chemotherapy; however, concerns over residues, eco-
toxicity and the development of acaricide resistance
have led to questions being raised regarding the sustain-
ability of current strategies and an interest in the devel-
opment of alternative control methods [4,5]. The
chemicals used to treat sheep scab are also relied upon
for control of gastrointestinal (GI) parasites, as such lim-
iting their use in sheep scab control is essential to
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parasites, prolonging drug efficacy for these economic-
ally important diseases [6]. Strategies designed to con-
trol the spread of sheep scab are reliant upon the
availability of a diagnostic assay capable of accurately
detecting infested animals, thus enabling effective quar-
antine and treatment. A major problem in disease con-
trol is the rapid spread of infestation, normally via direct
contact or by transfer of mites from infested fleece,
fence posts, farm or veterinary machinery and workers
[3,7]. During the early stages infestations are not obvious
and animals often appear clinically normal [7,8]. This
subclinical stage can last for several weeks during which
animals can act as a source of mites [7,8]. At present,
diagnosis of sheep scab is based upon animal history,
clinical signs and confirmation through identification of
P. ovis mites in scrapings from lesional skin [8]. Inevita-
bly, animals with sub-clinical infestations or minimal
lesions will evade detection. For control or eradication
programs to be successful it is crucial that all infested
animals are identified, including subclinical cases.
Targeted treatments of P. ovis-infested sheep, based on
flock serology, have been used successfully to reduce the
incidence of sheep scab [9,10]. Our group has recently
developed a novel diagnostic enzyme linked immunosor-
bent assay (ELISA) capable of accurately detecting P. ovis
infestation in sheep [11]. Unlike previous tests, this assay
is based on detection of host antibodies specific to a
recombinant mite allergen, termed Pso o 2 (rPso o 2) and
in our hands, has proven to be sufficiently sensitive to
detect sheep scab infestation within 2-3 weeks of contact.
This paper describes the first use of this diagnostic assay
for the analysis of a natural outbreak of sheep scab that
occurred during 2009 within an experimental flock at the
Moredun Research Institute, Edinburgh. The study
involved the collection of sera from animals at three
dates; these coincidentally occurred prior to the outbreak
of sheep scab, shortly after clinical signs of sheep scab
appeared in the flock and finally after the flock was trea-
ted. Fortuitously this allowed analysis of antibody levels
in individual animals over the course of sheep scab infes-
tation and also enabled association of antibody levels
with observed clinical signs. This analysis has further
demonstrated the ability of this diagnostic assay to accu-
rately detect sheep scab infestation in a natural outbreak
and, more importantly, highlights the potential of the




The study described herein was designed to assess differ-
ences between treatment regimes for natural infections
of GI parasites of sheep and was not designed for the
analysis of a sheep scab outbreak. Ethical approval for the
study was obtained from the Moredun Research Institute
Experiments Committee. All serum samples described in
this study were taken from the original trial. Archived
samples were made available to the authors for analysis
once it was apparent that sheep scab was present within
the group, as such no further ethical approval was
required or sought. 160 twin Texel-cross lambs reared at
the Moredun Research Institute, Edinburgh were sepa-
rated along with their Ewes into eight individually fenced
one acre paddocks (Paddocks 1-8), with 20 lambs per
paddock (12/05/09). Each paddock (1-8) was separated
by single fencing and isolated from the outside by double
fencing, or single fencing and an empty paddock. Ani-
mals were handled within an exclusive on-site facility
adjacent to paddock 2 and processed in paddock order
starting with paddock 1 and ending with paddock 8.
Blood samples were taken at three dates; pre-outbreak
(23/06/2009), mid-outbreak (31/08/2009) and post-treat-
ment (13/10/2009). In addition, later stage serum sam-
ples were obtained from 33 randomly selected animals
from the same trial on the 13/05/2010 to assess the long-
evity of the antibody response.
Sheep scab was diagnosed on a separate area of the
farm (16/06/09) however, the study animals were unaf-
fected at this time. Ewes were briefly removed from their
lambs to be clipped; this was carried out in a shared facil-
ity on the Institute farm (07/07/2009) and ewes were
then moved back to their respective paddocks. Shortly
afterwards the lambs were weaned (14/07/2009) and
ewes moved to fresh pasture. Sheep scab was subse-
quently observed in the study animals (initially in Pad-
dock 5) (24/08/09). All sheep were assessed by visual
inspection of the fleece and skin for clinical signs of
sheep scab (31/08/09). The following parameters were
assessed; 1) physical, i.e. obvious presence of mites, stain-
ing or removal of fleece and evidence of skin lesions; 2)
behavioural, i.e. signs of discomfort or excessive itching
and an itch response (lip smacking) following contact.
Based on these parameters, each animal was assigned a
clinical score from 0-5, depending on the severity of clin-
ical signs. Mild physical signs were classified as staining
or removal of fleece but with no obvious lesions or pre-
sence of mites. Moderate physical signs as staining or
removal of fleece combined with the presence of skin
lesions. Severe physical signs were defined as staining
and removal of fleece, obvious skin lesions and presence
of mites. Mild behavioural signs were defined as excessive
itching and discomfort. Moderate behavioural signs as
excessive itching and discomfort combined with a mild
itch response following contact with lesional skin. Severe
behavioural signs as excessive itching and discomfort
combined with a strong itch response following contact
with lesional skin. All sheep in the study were dipped
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for sheep scab, with the treatment being repeated after
clinical signs persisted in some animals (30/09/2009).
Sample handling and preparation
Whole blood samples were collected into vacutainer
tubes without anti-coagulant and clotted overnight at
+4°C. Samples were centrifuged at 5,000 g for 5 minutes
at room temperature, serum removed by decanting and
stored at -20°C.
ELISA sample processing
Recombinant Pso o 2 (rPso o 2) antigen was produced for
the ELISA as previously described [11] and samples were
analysed in duplicate with the sheep scab diagnostic
ELISA following a standard operating procedure as pre-
viously described [11]. Plates were read at 450 nm on a
microplate reader (Tecan, UK) and well OD values were
obtained. Positive controls consisted of pooled hyper-
immune sera (animals experimentally infested with
P. ovis for a second time, following a primary infestation
and successful treatment) diluted 1 in 200 to give an
OD450 of 0.85 (± 20%), and this sample was included on
each plate as an interplate control. Plate readings were
normalised to that OD450 reading and any control sample
outside the range ± 20% of OD450 0.85 led to the plate
being repeated. Sample test readings were averaged, nor-
malised to the control and the average background read-
ing for each plate subtracted from the test readings to
produce an adjusted/corrected sample reading.
Data analysis - interpretation
We previously described the analysis of 433 P. ovis-
negative and 58 P. ovis-positive samples using this
ELISA [11]. The data were analysed using receiver
operator characteristic (ROC) curves [12,13] in order to
determine an OD450 threshold above which a sample
from a sheep with unknown disease status could be
classified as positive for P. ovis infestation [11]. Using
these reference data, it was concluded that samples
should be considered positive for sheep scab if the
adjusted sample test OD450 reading was > 0.06 absor-
bance units (AU). Using this threshold the assay pro-
vided a test sensitivity of 0.93 and a specificity of 0.9.
Following this regime, serum samples taken from each
animal were classified as being either positive or nega-
tive for scab. The classification scheme used to define
T P ,F P ,T Na n dF Ns a m p l e sw a sa sf o l l o w s :T P=A n i -
mal with disease correctly classified as positive; TN =
Animal without disease correctly classified as negative;
FP = Animal without disease incorrectly classified as
positive; FN = Animal with disease incorrectly classified
as negative.
Statistical analysis
All data analyses were conducted in R [14]. A general lin-
ear model was used to analyse log (ELISA OD450)+
0.005 between paddocks over the three sample times.
This was deemed appropriate as the errors from the
model were normally distributed. Comparison of the
number of animals over the cut-off to the number under
the cut-off was analysed using a generalised linear bino-
mial model with logistic link. Non-parametric techniques
were used to compare groups of ELISA OD450 values
otherwise. These included Kruskal-Wallace analysis,
where multiple groups were compared (e.g. comparing
paddocks or clinical indices), and Mann-Whitney U test,
where there were two groups (e.g. clinical vs non-clini-
cal). Table 4 was generated following analysis of the data
using a binomial generalised linear model, which demon-
strated that the best model was one with paddock, time-
point and an interaction between the two. However, due
t ot h es p a r s i t yo ft h ec o n t i n g e n c yt a b l e ,m a n ys t a n d a r d
errors of the parameters were inappropriately high.
Therefore, a bespoke function was written to calculate
the likelihood for the model. This was then maximised to
determine the maximum likelihood estimators. The
values for each parameter which increased the deviance
(-2*log-likelihood) by 3.84 (5% critical value of the Chis-
quare distribution with 1 degree of freedom) represent
the limits of the 95% confidence interval for that para-
meter. To ascertain whether there was any difference
between ELISA values in clinical and non-clinically
affected animals it is not sufficient to demonstrate that
there is no significant difference between groups, as this
could be a result of low animal numbers and a resulting
lack of power. Formally, the statistical test needs to be
formulated as an equivalence problem. The Mann-Whit-
ney U statistic can be used to determine the area under
the receiver operating characteristic (ROC) curve (the
AUC) [15]. If a test is perfectly unable to distinguish
between two groups then the theoretical value of the
AUC is precisely 0.5 [15]. We assumed that a test cannot
distinguish between groups if this value lies between 0.3
and 0.7 (the ROC curve being symmetric if we invert the
test).
Results
Clinical signs of disease
Twenty seven of the 160 animals presented with clinical
signs of sheep scab infestation, ranging from very mild to
severe (Table 1). Twelve animals showed behavioural
signs of infestation but no obvious physical signs (Clinical
score = 1). Six animals showed mild physical signs but no
obvious behavioural signs (Clinical score = 2). A single
animal in paddock 5 presented with mild physical and
behavioural signs (Clinical score = 3), whilst a further 4
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(Clinical score = 4). Four animals showed severe physical
and behavioural signs (Clinical score = 5) and one animal
died of an unrelated cause prior to the physical examina-
tion. The remaining 132 animals showed no obvious phy-
sical or behavioural signs (Clinical score = 0).
Comparison of ELISA results with clinical signs
At the mid-outbreak sampling point 27 animals showed
varying degrees of clinical signs. None had pre-outbreak
OD450 ELISA values > 0.06, indicating that they were
negative pre-outbreak. At the same sampling point 25 of
these clinically positive animals had OD450 values > 0.06,
one was below this cut-off, and one sample was unobtain-
able. The two animals without positive ELISA readings at
the mid-outbreak sampling period had OD450 values
above the threshold at the subsequent sampling, indicating
either very early infestation or a delayed reaction. Of the
130 animals for which OD450 values were available pre-
outbreak, 124 had OD450 values < 0.06 and six > 0.06: thus
representing potential false positives (FPs). At the mid-
outbreak sampling 105 of the 132 clinically negative ani-
mals had OD450 values > 0.06, 23 of these were below the
cut-off, and 4 samples were unobtainable. At the post-
treatment sample the OD450 values of 70 of the 132 sam-
ples were > 0.06, 59 were below the cut-off and 3 were
unobtainable. The clinically negative, test positive group
will include both FP and sub-clinically affected animals.
The specificity of the test has previously been estimated
at 0.90 [11]. Therefore, if the 23 (27 if we include the 4
unobtainable results) clinically negative, test negative ani-
mals represent 90% of all truly negative animals then we
would expect 2.6 (3) FPs. We can therefore infer that the
majority of the 105 test-positive, clinically negative ani-
mals represent sub-clinical inf e s t a t i o n s .T oc o m p a r et h e
performance of the test in clinical and sub-clinical ani-
mals we can compare the distribution of OD450 values
from all clinically positive animals with those which were
clinically negative but test positive. Since we believe that
the majority of the latter group represent sub-clinical
cases, any bias due to misclassification should be small.
There was no statistically significant difference between
the median OD450 values of non-clinical, above-threshold
animals and animals with each of the five levels of clinical
signs recorded (Kruskal-Wallace chi-squared = 7.20, p =
0.21). Due to the low numbers of animals with clinical
signs these animals were combined into a single group
and again no significant difference in average location sta-
tistic was observed between these and the non-clinical,
above threshold animals (Mann-Whitney U = 1166, p =
0.39). To check the sensitivity of these results to the choice
of cut-off, the analysis was repeated using OD450 cut-offs
of 0.04 (Mann-Whitney U = 1275, p = 0.27) and 0.10
(Mann-Whitney U = 309.5, p-value = 0.20). Using the pre-
defined OD450 cut-off of 0.06 to define sub-clinical cases,
the estimated AUC for the ability of the test to discrimi-
nate between clinical cases and non-clinical, above thresh-
old animals was 0.44 with a 95% confidence interval (0.32,
0.57). We can therefore conclude that there is no evidence
for differences in the distribution of ELISA values in the
clinical and non-clinical, above-threshold groups. We
therefore infer that at this cut-off value the test can equally
identify both clinical and sub-clinical cases.
Whilst these findings highlight the difficulty of diagnos-
ing sheep scab through the presence of physical or beha-
vioural signs alone, they may also provide a demonstration
of the ability of the ELISA to diagnose sub-clinical
infestation.
False positive and false negative samples
ELISA results were used to determine the infestation
status of all 160 animals throughout the course of the
outbreak (Table 2). At the pre-outbreak sampling date 6
animals tested positive and 152 negative (2 samples
were unavailable). At the mid-outbreak sampling date
120 animals tested positive and 34 negative (6 samples
were unavailable). At the post-treatment sampling date
90 animals tested positive and 65 negative (5 samples
were unavailable). Previo u sR O Cc u r v ea n a l y s i so f
ELISA test results from 491 clinically negative (n = 433)
and positive (n = 58) samples showed that the AUC was
0.97, which equates to a test accuracy of 97%, indicating
an excellent level of discrimination between clinical
cases and P. ovis-free animals [11,15]. Using the OD450
threshold of > 0.06 AU the ELISA showed a test sensi-
tivity of 93% and test specificity of 90% [11]. As such we
would expect to be able to accurately define 90% of true
negative (TN) samples and 93% of true positive (TP)
samples, leaving 10% FP and 7% false negative (FN)
samples.
The identification of 6 potential FPs during this study
(3.8%) was in fact significantly (p ≤ 0.009) lower than
Table 1 Clinical scores mid-outbreak
Clinical Score Number of animals Paddock Number
0 132
# All
1 12 2, 6*, 7, 8
2 65 , 7
3 15
4 45 , 6
5 45
Distribution of clinical scores following inspection of animals at the mid-
outbreak sampling. 0 = No obvious physical or behavioural signs; 1 = Mild
behavioural but no obvious physical signs; 2 = Mild physical signs but no
obvious behavioural signs; 3 = Mild physical signs combined with mild
behavioural signs; 4 = Moderate physical signs combined with moderate
behavioural signs; 5 = Obvious and severe physical signs combined with
severe behavioural signs. *One serum sample unavailable at the mid-outbreak
sampling.
#One animal died of an unrelated cause.
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estimates of test properties [11] and hints at a previous
under-estimation of the test specificity (here estimated
to be 96.2% but previously 90%). FNs were more diffi-
cult to define. However, these can be classified as ani-
mals with clinical signs of disease but with a negative
test result. In this case we observed 2 FNs that had clin-
ical scores of 1 and 4 respectively during the mid-out-
break assessment and both had ELISA OD450 levels <
0.06 at this time point. However, both were then cor-
rectly classified as positive at the subsequent sampling
period. This demonstrates a FN rate of 2/27 animals
(7.4%) which is not out of line with the predicted 7%
rate of FNs based on previous estimations (p = 0.94). It
also demonstrates that test sensitivity strongly depends
on the infestation history of the animals being tested, an
aspect of the epidemiology which will be explored more
thoroughly in the next section.
Analysis of antibody levels over the course of infestation
The antibody levels for all animals in the study at each
time point are summarised in Table 2 and presented in
Figure 1. There were significant differences in the mean
ELISA OD450 levels pre-outbreak vs.m i d - o u t b r e a k ,p r e -
outbreak vs. post-treatment and mid-outbreak vs.p o s t -
treatment (p ≤0.0001). Low numbers of potential FPs (n =
6) were observed at the pre-outbreak sampling period
(mean OD450 = 0.01) whilst all clinically positive animals
were successfully classified by their mid-outbreak or post-
treatment sample along with a number of sub-clinical
cases (mean OD450 = 0.12). From the data presented in
Figure 1 and Table 2 it can be seen that post-treatment
the overall mean OD450 dropped significantly to 0.08 (p ≤
0.001), highlighting the reduction in antibody levels across
the flock within 6 weeks post-treatment.
Paddock data analysis
Fourteen animals remained negative throughout the study
with ELISA results below the OD450 threshold of > 0.06
(mean OD450 = 0.023, range = 0.00 - 0.06) and showing
no clinical signs. These animals were spread throughout
p a d d o c k s( p )1 - 6( p 1n=3 ,p 2n=3 ,p 3n=4 ,p 4n=2 ,
p5 n = 1, p6 n = 1) with no negative animals observed in
paddocks 7 and 8. A single animal was classified positive
throughout the study (paddock 8); in fact, its serum anti-
body levels increased consistently throughout the study,
peaking post-treatment indicating that this animal may
have been a FP even at the pre-outbreak sampling date. As
would be expected the majority (141 of 160 or 88%) of ani-
mals were classified as positive at either the mid-outbreak,
or the post-treatment sampling period. A majority of these
animals can be classified into one of three groups: Group
1 = negative pre-outbreak and positive at the remaining
two sampling dates (n = 68); Group 2 = negative pre- and
mid-outbreak but positive post-treatment (n = 15); Group
3 = negative pre-outbreak, positive mid-outbreak and
negative again post-treatment (n = 45). Two interesting
patterns were observed with these animals (Figure 2),
Groups 1 and 2 were spatially distinct with the majority of
these animals located in paddocks 4-8 (p1 n = 1, p2 n = 4,
p3 n = 3, p4 n = 13, p5 n = 14, p6 n = 15, p7 n = 19, p8
n = 14). Group 3 formed a spatial complement, with the
majority of animals located in paddocks 1-5 (p1 n = 15, p2
n = 11, p3 n = 9, p4 n = 5, p5 n = 4, p6 n = 1). The
remaining animals which tested positive by ELISA during
the outbreak belonged to one of 4 additional groups all of
which were small in number and a number of which prob-
ably represented FP animals: i) positive pre- and mid-out-
break, and negative post-treatment (n = 2, paddocks 2 and
3); ii) positive pre-outbreak and negative for the remaining
samples (n = 1, paddock 3); iii) positive pre-outbreak and
post-treatment but negative mid-outbreak (n = 2, pad-
docks 6 and 8); or iv) animals for which samples were una-
vailable at one or more time points (n = 12).
To identify effects attributable to individual paddocks
we applied a binomial test model to the longitudinal data
using the optimum test cut-off of an OD450 >0 . 0 6 ,w i t h
all results being classified as either test positive or nega-
t i v e .T h i sa n a l y s i sd e m o n s t r a t e dt h a tn op a d d o c k sw e r e
significantly different from the overall average during the
mid-outbreak sampling period, although paddock 8 was
at marginally significantly lower probability of demon-
strating positive tests (p < 0.1) (Table 3). However, post-
treatment, paddocks 1-3 had statistically significantly
(p < 0.05) lower probabilities of demonstrating positive
results, while paddocks 7 and 8 showed statistically sig-
nificantly higher levels (p < 0.05) of test positivity than
the mid-outbreak average (Table 3). These results point
Table 2 Distribution of animals classified as positive or negative by ELISA and mean antibody levels during outbreak
of sheep scab
Sampling time Positive Negative Other Mean antibody level Range Standard error (SEM)
Pre-outbreak 6 152 2 0.01 0 - 0.11 0.0016
Mid-outbreak 120 34 6* 0.12 0.01 - 1.16 0.01
Post-treatment 90 65 5* 0.08 0 - 0.47 0.0056
Numbers of animals classified as positive or negative for sheep scab based on their ELISA results throughout the outbreak. Positive animals classified as having
an OD450 value > 0.06. Also shown are the mean ELISA OD450 values, the range of values across all 160 animals throughout the outbreak of sheep scab and the
standard error associated with each mean.*1 animal died of an unrelated cause, other samples unavailable due to unobtainable serum samples.
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paddocks, with paddocks 1-3 showing a more rapid or
stronger recovery post-treatment than paddocks 7 and 8.
The reasons behind this paddock effect are unclear, how-
ever, may be due to the way in which the disease spread
within and between individual paddocks, or be influenced
by the order in which the animals within each paddock
were handled and treated (See Discussion).
Antibody longevity analysis
To assess the longevity of the antibody responses to
P. ovis Pso o 2 antigen, samples were obtained from 33
animals from the same trial nine months after the sheep
scab outbreak was noticed and eight months post-treat-
ment. All animals tested had previously been classified as
positive for sheep scab from the ELISA results of either
their mid-outbreak or post-treatment samples. Twenty
seven animals (81%) were negative for sheep scab eight
months post-treatment, with levels of circulating anti-
body that would be considered negative, using the pro-
posed cut-off value (mean OD450 =0 . 0 2( r a n g e=0-
0.06)). Six of the 33 animals remained positive for sheep
scab (19%) with low or border line OD450 values (mean =
0.076 (range = 0.07 - 0.1), and the OD450 values for 4 of
these 6 animals were in fact lower than their respective
OD450 values taken 2 weeks post-treatment (13/10/2009),
indicating a slow decrease in the antibody response.
These results are consistent with the level of circulating
antibody observed in infested animals being transient,
declining following treatment.
Discussion
Here we have shown that this diagnostic assay for the
serological detection of sheep scab infestation [11] is able
to effectively detect disease during a natural outbreak.
This analysis has also demonstrated the ability of the
assay to detect sub-clinical disease and has shown that
the level of circulating antibody diminishes with time
after successful treatment, both of which are crucial attri-
butes during any future control program.
False positive and false negative samples
The threshold of > 0.06 AU for ELISA readings (OD450)
delivers a test sensitivity of 0.93 and specificity of 0.9
[11]. At this threshold the ELISA identified 6 potential















Figure 1 Scatter plot of individual antibody levels during sheep scab outbreak. Horizontal black line indicates the 0.06 OD450 threshold
above which samples were classified as positive for sheep scab. Animals were treated after the mid-outbreak sampling point. Group means
indicated by black horizontal lines within individual scatter plots. Thirty seven extreme values (OD 450 values > 0.2) removed from mid-outbreak
and post-treatment sample sets to aid with data visualisation, though still contributed to summary statistics.
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negative ELISA result). Although the number of FNs was
in line with previous understanding of the test properties,
suggesting that the sensitivity in the field is equivalent to
that estimated previously, the level of FPs was signifi-
cantly lower than expected and may indicate a higher
overall test specificity (96.2%); where this has previously
been estimated as 90% [11]. This may indicate that sam-
ples used in the calculation of the original OD450 thresh-
old were not representative of the population of negative
animals. This is borne out by a result in the original
paper which compared a further 20 negative animals and
found them to have significantly lower OD450 values.
Altering the threshold above which we classify a sample
as positive will also change the test sensitivity and specifi-
city and therefore alter the number of FP and FN results
[16]. For example, increasing the threshold OD450 to 0.1
absorbance units would provide predicted test sensitivity
and specificity of 79.3% and 99.1%, respectively, thus
biasing the test towards increased specificity and there-
fore reducing the number of FPs, whilst increasing the
number of FNs. In contrast, reducing the threshold
would have the opposite effect, biasing the test towards
increased sensitivity at the expense of specificity, increas-
ing the number of FPs whilst reducing the number of
 
Groups 
1 & 2 
Group 3 
Figure 2 Mean antibody levels across all paddocks throughout the outbreak. Vertical blue arrow indicates treatment. Horizontal red line
indicates 0.06 OD450 cut-off. Groups 1 and 2 (mean positive for sheep scab post-treatment) covers paddocks 5-8 and Group 3 (mean negative
post-treatment) 1-4.
Table 3 Data from the fitting of a binomial model to
longitudinal data
Paddock Sampling Period RR 95% CI
1 Mid-outbreak 1.07 0.86-1.16
2 Mid-outbreak 1.12 0.93-1.18
3 Mid-outbreak 0.95 0.70-1.10
4 Mid-outbreak 0.89 0.64-1.06
5 Mid-outbreak 1.07 0.86-1.16
6 Mid-outbreak 1.06 0.84-1.16
7 Mid-outbreak 0.93 0.68-1.10
8 Mid-outbreak 0.91 0.63-1.09
1 Post-treatment 0.063 0.0047-0.25
2 Post-treatment 0.24 0.079-0.48
3 Post-treatment 0.18 0.047-0.41
4 Post-treatment 0.83 0.57-1.03
5 Post-treatment 1.00 0.76-1.13
6 Post-treatment 1.12 0.93-1.18
7 Post-treatment 1.18 1.08-1.18
8 Post-treatment 1.18 1.06-1.18
All Relative Risk (RR) are relative to the mean risk at the mid-outbreak
sampling period. Estimates with statistically significant (p < 0.05) p-values
shown in bold type. Estimates with marginally significant (p < 0.1) p-value in
italics.
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a balance between specificity and sensitivity for optimal
test performance [16-18]. For sheep scab, an ideal test
would aim to reduce the rate of FPs as these could lead
to unnecessary quarantine and/or treatment of non-
infested flocks with the financial implications of unneces-
sary treatment. Biasing the assay towards the reduction
of FPs leads to a moderate increase in the number of
FNs, and with this type of diagnostic assay FNs are una-
voidable. However, this test is expected to be used on a
number of animals simultaneously that represent either a
whole flock, or a group of co-housed animals. If any ani-
mal is positive then the whole group would be treated.
Due to the rapid spread, it is unlikely that only a single
animal in a group of sheep would be infested, so, even
with two truly positive animals among the tested animals
the probability that the group is missed and therefore not
treated is reduced to 7.4% in the above example (group
sensitivity of 92.6%). Further cost modeling would allow
the determination of the optimum cut-off depending on
the presence or absence of clinical signs and manage-
ment of the animals, i.e. hill vs. lowland flocks, where
increased density of lowland farming could lead to a
more rapid spread of infestation. Although the results
shown here suggest greater test sensitivity and specificity
than previously thought, the ideal threshold may be
slightly higher than the OD450 > 0.06 described herein -
for example the cut-off of 0.1 discussed above would
reduce the level of FPs to less than 1% whilst increasing
the level of FNs to approximately 10%, which may repre-
sent a good compromise.
Comparison of ELISA results with clinical signs
We have demonstrated that there is no evidence that the
ELISA values for clinical and non-clinical, above thresh-
old animals come from anything other than indistin-
guishable distributions using this test. Since most of the
non-clinical, above threshold animals are likely to repre-
sent sub-clinical cases this indicates that the test is
equally able to detect sub-clinical as clinical cases if their
OD450 value is above threshold. It is likely that the
response measured by the ELISA is an early response to
the presence of the mites, and not affected by the degree
of damage caused by the mites or self-trauma. This is
crucial for any Psoroptes-diagnostic assay as the success
of any disease control or eradication program is entirely
dependent on the availability of a diagnostic assay sensi-
tive enough to identify diseased animals prior to the
advent of clinical signs. This is important for sheep scab,
as animals with obvious physical and behavioural signs
are relatively straightforward for a trained veterinarian or
experienced farmer to diagnose but sub-clinical animals
provide a far greater challenge to disease control. How-
ever, it should be noted that we cannot unequivocally
state that the sub-clinical animals detected in this study
would have gone on to develop clinical disease due to the
ethical and legal duty to treat all suspected animals. The
fact that all but five of these potentially sub-clinical ani-
mals were serologically negative pre-infestation, along
with the low levels of cross-reactivity detected with other
parasitic diseases of sheep including gastrointestinal
nematodes, keds and lice, adds further support to these
findings [11]. The fact that these sheep were maintained
in paddocks with known infested animals points to an
obvious source of infestation and this is further sup-
ported by a previous study which demonstrated the
active spread of sheep scab in a matter of weeks across a
flock of sheep following the introduction of single
infested animals [19].
Analysis of antibody levels over the course of infestation
The presence of highly statistically significant (p ≤0.001)
differences between the average antibody levels seen in
pre-outbreak, mid-outbreak and post-treatment sampling
periods in this study demonstrates that the ELISA was
capable of both accurately detecting sheep scab and of
reflecting changes in disease following treatment. In con-
junction with our previous analysis [11] this offers further
validated support for the use of this test in any future
sheep scab control or eradication program.
Paddock data analysis
The outbreak was first noticed with the appearance of
clinical signs within paddocks 5 and 6 and the majority
of animals (19/27) showing obvious clinical signs mid-
outbreak were located within these paddocks. The
remaining clinical animals were spread across the pad-
docks. Paddocks 5 and 6 had more noticeable infestations
than the other paddocks and this was expressed in both
the ELISA data and clinical scores offering further sup-
port for the hypothesis that the outbreak may have
started in Paddock 5. All animals were processed in a
specific order, once every two weeks, starting with pad-
dock 1 and ending with paddock 8, with one paddock
being processed at a time before being returned to their
original paddock. P. ovis mites are able to survive off host
for up to 38 days, but may only remain infective for 15-
16 days [20,21]. It is therefore unlikely that mites would
have been transferred from paddock 5 to animals in pad-
docks 1-4 as two weeks would pass before these animals
came back through the shared handling facility. Conver-
sely, animals in paddocks 6-8 were processed directly
after the animals in paddock 5. Therefore if we assume
that the infestation began in paddock 5, then paddocks 6-
8 would have had an increased risk of mite exposure
compared to animals in paddocks 1-4. It should also be
noted that individual paddocks were separated by single
fencing: as such, transfer of mites between adjacent
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ited. This hypothesis is supported by the ELISA data,
with paddocks 7-8 showing statistically significantly
higher mean levels of test positivity and paddocks 1-3
showing statistically significantly lower mean test positiv-
ity post-treatment (Table 3). Another hypothesis relates
to the dipping regime applied to these animals; again this
was performed in paddock order. Dipping was performed
using an automated dipping apparatus processing one
paddock (20 animals) at a time, with fresh dip being
added after approximately 30 animals. However, post-
treatment, the animals in paddocks 6-8 continued to
show clinical signs, and as such, all animals in the study
were dipped for a second time. It is possible that the ani-
mals in paddocks 6-8 did not get sufficient levels of acari-
cide to effectively kill all mites upon first treatment. This
could be due to depletion or fouling of the chemicals in
the dip during the dipping of the earlier paddocks. How-
ever, this cannot be confirmed and the dip was regularly
topped up, although it could explain the need for an addi-
tional treatment in these paddocks and the significantly
higher levels of test positivity observed. Unfortunately it is
impossible to confirm either of these hypotheses although
they may partly explain why the ELISA results for animals
in paddocks 5-8 appeared to decline more slowly than
those in paddocks 1-4 following treatment.
Fourteen animals were found to be negative through-
out the study and these were spread across paddocks 1-
6. Interestingly, paddocks 5 and 6 had only one negative
animal each, with no negative animals being found in
paddocks 7 and 8 and this may offer further support for
the explanation described above.
Antibody longevity analysis
An important feature of a good diagnostic assay is the abil-
ity to discriminate between animals with disease and those
that were previously infested but are now disease-free. One
of the drawbacks of antibody-based diagnostic assays is the
persistence of the antibodies in the circulation, which can
lead to FP results following treatment. Encouragingly, the
data presented here show that the level of circulating anti-
bodies with specificity to Pso o 2 reduced with time with
only borderline responses detectable in a few of the tested
animals (19%) 8 months post-treatment. This is consistent
with previous studies which have shown that P. ovis-speci-
fic antibodies may persist in the circulation 3-9 months
after treatment (Peter Bates, Personal Communication).
These findings show that the circulating antibodies are
transient, declining following treatment and indicating that
their impact on the level of FPs is likely to be minimal.
Source of sheep scab outbreak
It is not possible to definitively identify the source of the
sheep scab outbreak within this experimental flock.
However, it is highly likely that sheep scab was intro-
duced into paddock 5 when the ewes were clipped at
the farm’s shared handling facility. At this point animals
were moved from a very low risk area of effective quar-
antine into a shared facility which posed a much higher
risk of infestation and it was at this stage that the
chances of exposure from the outbreak prevalent in
other parts of the farm were at their greatest.
Conclusions
The occurrence of a natural outbreak of sheep scab
within an experimental flock enabled the analysis of the
performance of a diagnostic ELISA in an environment
where samples were available from all animals pre-infes-
tation, mid-outbreak and post-treatment. This situation
facilitated the validation of the ELISA, further demon-
strating its ability to detect disease in a natural outbreak,
not only in animals with obvious clinical signs but more
importantly in animals showing no physical or beha-
vioural signs, but that had been ‘in contact’ with infested
animals. This latter sub-clinical group are far more
important from a disease control perspective, because if
undetected they may act as a source of infestation
exacerbating disease spread. The ELISA described herein
employing a single recombinant protein represents a
major step forward for the diagnosis of sheep scab and
may be critical in any future control program.
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